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Abstract
Primary tumors of the heart are rare, but they are often associated with refractory arrhythmias. 
Vascular tumors of the heart comprise a small minority of primary cardiac tumors. In patients 
with   structurally   normal   hearts,   ventricular   tachycardia   (VT)   originating   from   the   right 
ventricular outflow tract (RVOT) can be sensitive to adenosine, vagal maneuvers, and calcium 
channel blockers. In this report, we describe a case of ventricular tachycardia originating from 
within   a   hemangioma   in   the   RVOT   that   was   ultimately   controlled   with   verapamil.
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Case   report                                                                                  
A 15 year old girl presented with a recurrence of ventricular tachycardia after having been 
externally cardioverted twice in a 24 hour period at a referring hospital. She had been diagnosed 
with a cardiac hemangioma when a murmur was noted at 5 years of age on a routine physical 
exam. Echocardiogram at that time showed a large mass in the RVOT with mild obstruction. 
Endomyocardial   biopsy   showed   a   non-specific   vascular   proliferation.   A   histopathologic 
diagnosis was confirmed when the tumor was resected shortly after the initial presentation. The 
tumor was infiltrative and encroached on the RVOT free wall and tricuspid valve, and hence was 
only incompletely resected. She continued to do well, and at 10 years of age, non-sustained 
polymorphic VT was noted on a routine screening Holter monitor. An EP study was performed 
and ventricular double extrastimuli (600:290:270) provoked sustained polymorphic VT. At that 
time, a transvenous single-chamber internal cardioverter defibrillator (ICD) was placed for 
primary prevention and the patient was started on Nadolol.                                                   
She remained asymptomatic for the next five years. Frequent episodes of non-sustained 
polymorphic VT were noted, but there were no ICD therapies or episodes of sustained VT. At 15 
years of age, she presented to the emergency room with palpitations and 12-lead ECG 
demonstrated wide complex tachycardia at 180 bpm (shown in  Figure 1  after amiodarone 
loading). The ICD was functioning appropriately, but the  arrhythmia  rate  was  slower  than  the 
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defined VT/VF rate of 200 bpm, and hence no therapies were delivered. Tachycardia apparently 
terminated with amiodarone and she was discharged to home. She presented two days later with 
the same rhythm. On that occasion, both intravenous amiodarone and lidocaine had no effect on 
the rhythm, and external cardioversion with 50J restored sinus rhythm. 
Figure 1: Ventricular Tachycardia (slowed after loading with amiodarone)
She was then transferred to our institution where Sotalol was initiated at 80 mg twice a day. 
Ventricular tachycardia recurred, and on both occasions was terminated with antitachycardia 
pacing using her ICD (Figure 2). Sotalol was discontinued and therapy was transitioned to 
amiodarone and nadolol. The patient continued to have frequent episodes of VT despite several 
combinations of antiarrhythmic drugs including amiodarone, lidocaine and esmolol. Tachycardia 
could be reliably terminated with ventricular burst pacing from the ICD. The patient also 
reported that on several occasions she was able to successfully terminate tachycardia with vagal 
maneuvers. Adenosine was given during one episode and did not affect tachycardia. 
When daily episodes of VT persisted despite maximal doses of amiodarone and nadolol, 
antiarrhythmic medications were discontinued for electrophysiology study and possible ablation. 
Left coronary angiography was performed at the beginning of the case, revealing a coronary 
fistula from the left coronary artery to the RV with a large contrast-filling vascular mass 
encircling the left coronary artery. Right coronary angiography demonstrated the same contrast-
filling mass encircling the right coronary. The mass was presumed to be residual hemangioma 
with multiple blood supplies. A trans-esophageal echo with 2D and color doppler was also done, 
and showed the hemangioma to extend from the mid-portion of the RV septum to just under the 
pulmonary valve. At EP study, only several beats of nonsustained monomorphic VT were 
induced   in   the   baseline   state.   Isoproterenol   was   infused,   and   longer   runs   of   sustained 
monomorphic  VT  were reliably  induced   with ventricular   burst pacing,  ventricular   triple 
extrastimuli, and with rapid atrial pacing. Attempts were made to perform entrainment mapping 
but were not successful because on some occasions tachycardia terminated with ventricular 
pacing, and on other attempts reliable capture could not be confirmed. Tachycardia terminated 
multiple times during the study. Termination was spontaneous and not associated with premature 
ectopic beats. Tachycardia could reliably be reinitiated on isoproterenol, both with ventricular 
burst pacing and with ventricular triple extrastimuli (500:320:320:280).  
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 Figure 2: Ventricular tachycardia is terminated with ventricular burst pacing from the ICD.
During sustained ventricular tachycardia, 3D mapping with CARTO was initially performed 
using a Biosense Webster EZ Steer catheter (4mm tip). Earliest areas of ventricular activation in 
tachycardia were noted along the border of the tumor, and earliest ventricular activation 
preceeded the QRS by 41 msec. Initial lesions placed along the tumor border were unsuccessful. 
Pace mapping from these sites showed paced QRS morphology similar to VT morphology in 11 
of 12 surface leads. With similar findings at several points on the tumor border, the conclusion 
was made that tachycardia originated from within the tumor. Attempts to isolate the tumor with a 
series of lesions using an irrigated Navistar ThermoCool catheter were ultimately unsuccessful 
and tachycardia persisted. The case was ended and the patient was transferred back to the PICU 
in sinus rhythm. She underwent an upgrade to a dual chamber ICD with the intention of giving 
aggressive   beta-blocker   therapy.                                                              
Sustained tachycardia recurred and intravenous verapamil, which had previously not been tried, 
was given and tachycardia terminated.  Oral verapamil was continued and there were no further 
tachycardia recurrences. She was started on oral Verapamil SR 240 mg daily and discharged 
from the hospital. She continued on Verapamil and did not have any recurrent episodes for one 
year. Subsequently, during a vigorous exercise the patient experienced two appropriate shocks. 
She had been noncompliant and was not taking verapamil at the time. Electrograms from the 
device demonstrated sinus tachycardia prior to an episode of VT (Figure 3). 
Discussion
Cardiac hemangiomas are composed of a benign proliferation of endothelial cells and blood 
vessels, and they are histologically identical to hemangiomas found elsewhere in the body. 
Hemangiomas account for less than 3% of primary cardiac tumors [1,2].  
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Figure 3: Electrograms stored in the ICD demonstrate sinus tachycardia leading to sustained VT.  Anti-tachycardia 
pacing during charging is successful in terminating VT briefly before reinitiation and ultimate cardioversion to sinus 
tachycardia.  
Ventricular arrhythmias and sudden cardiac death are associated with a variety of cardiac tumors 
and are independent of tumor size [3,4]. Tumor associated arrhythmias are often refractory to anti-
arrhythmic medical therapies and successful radiofrequency ablation has been described [5].  
Tumor resection may be indicated in cases where less invasive therapies have failed [6].
Ventricular tachycardia arising from the RVOT in patients with structurally normal hearts has 
been characterized by cAMP-mediated triggered activity [7]. These arrhythmias are often sensitive 
to vagal maneuvers and calcium channel blockers. The arrhythmia described in this case displayed 
several features of triggered automaticity. Specifically, VT tended to occur while the patient was 
awake or active. Clinical episodes always initiated with a premature ventricular depolarization and 
were  not pause-dependant. At EP study, isoproterenol was required  to produce  sustained 
tachycardia. Tachycardia could also be reliably initiated with ventricular burst pacing, ventricular 
extrastimuli, and atrial pacing. Finally, the episode provoked by sinus tachycardia during vigorous 
exercise demonstrated rate-dependant arrhythmia triggering.                                                           
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Conclusions
This case illustrates that ventricular tachycardia arising from a hemangioma in the RVOT can act 
similar to VT arising from the RVOT in patients with structurally normal hearts. Tumor-associated 
ventricular tachycardias can be difficult to control with medication, and can also be difficult to 
treat with radiofrequency ablation. Verapamil should be considered before proceeding to tumor 
resection  or other  invasive therapies.                                                                       
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